Priscilla Auyeung, PhD, Diana Mittag, PhD, Philip D

Slides:



Advertisements
Similar presentations
Impaired TH17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy 
Advertisements

Comparison of the allergic and nonallergic CD4+ T-cell responses to the major dog allergen Can f 1  Suvi Parviainen, MSc, Antti Taivainen, MD, PhD, Aino.
Serum granzymes and CD30 are increased in children's milk protein sensitive enteropathy and celiac disease  Merja T. Augustin, MD, Jorma Kokkonen, MD,
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Erika Kajdácsi, MSc, Péter K
Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen- specific T-cell tolerance in human tonsils and peripheral blood 
Airway surface mycosis in chronic TH2-associated airway disease
Serum granzymes and CD30 are increased in children's milk protein sensitive enteropathy and celiac disease  Merja T. Augustin, MD, Jorma Kokkonen, MD,
Identification of drug- and drug-metabolite immune responses originating from both naive and memory T cells  Andrew Gibson, MRes, Lee Faulkner, PhD, Sally.
Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2  Natalija Novak, MD, Nihal Mete, MD, Caroline.
Reduced TH1/TH17 CD4 T-cell numbers are associated with impaired purified protein derivative–specific cytokine responses in patients with HIV-1 infection 
CD39: A new surface marker of mouse regulatory γδ T cells
Impaired TH17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy 
Jay A. Lieberman, MD, Faith R. Huang, MD, Hugh A
Differential cytokine induction by the human skin–associated autoallergen thioredoxin in sensitized patients with atopic dermatitis and healthy control.
Frank Kirstein, PhD, Natalie E
Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 
Histamine H2 receptor stimulation upregulates TH2 chemokine CCL17 production in human M2a macrophages  Susanne Mommert, PhD, Karl Gregor, MD, Kristine.
Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL- 5 and IL-5 receptor levels  Miguel L. Stein, MD, Joyce M. Villanueva,
Targeting Toll-like receptors on dendritic cells modifies the TH2 response to peanut allergens in vitro  Pierre Pochard, PhD, Brian Vickery, MD, M. Cecilia.
Reduction of CRKL expression in patients with partial DiGeorge syndrome is associated with impairment of T-cell functions  Mauro Giacomelli, PhD, Rajesh.
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Birch pollen immunotherapy results in long-term loss of Bet v 1–specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies 
Is 9 more than 2 also in allergic airway inflammation?
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Erika Kajdácsi, MSc, Péter K
Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen- specific T-cell tolerance in human tonsils and peripheral blood 
Clara cell 16-kd protein downregulates TH2 differentiation of human naive neonatal T cells  Sofi Johansson, MSc, Göran Wennergren, MD, PhD, Nils Åberg,
Frank Kirstein, PhD, Natalie E
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Carol J. Henderson, PhD, RD, J. Pablo Abonia, MD, Eileen C
Miriam Wittmann, MD, Jana Zeitvogel, Dong Wang, MD, Thomas Werfel, MD 
Ellen Mueller Fox, PhD, Marina N
The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria  Tse Wen Chang, PhD, Christina Chen, BS, Chien-Jen.
David M. Pyle, BS, Victoria S. Yang, MD, Rebecca S
Targeting Fel d 1 to FcγRI induces a novel variation of the TH2 response in subjects with cat allergy  Kathryn E. Hulse, BS, Amanda J. Reefer, MS, Victor.
Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation  Esra.
Allison K. Martin, BS, Douglas G. Mack, PhD, Michael T
Chronic cat allergen exposure induces a TH2 cell–dependent IgG4 response related to low sensitization  Amedee Renand, PhD, Luis D. Archila, MSc, John.
Brent E. Palmer, PhD, Douglas G. Mack, PhD, Allison K
β-Agonist enhances type 2 T-cell survival and accumulation
Thymic stromal lymphopoietin–activated invariant natural killer T cells trigger an innate allergic immune response in atopic dermatitis  Wen Hao Wu, PhD,
Peanut-specific type 1 regulatory T cells induced in vitro from allergic subjects are functionally impaired  Laurence Pellerin, PhD, Jennifer Anne Jenks,
Identification of drug- and drug-metabolite immune responses originating from both naive and memory T cells  Andrew Gibson, MRes, Lee Faulkner, PhD, Sally.
Notch signaling confers antigen-presenting cell functions on mast cells  Nobuhiro Nakano, PhD, Chiharu Nishiyama, PhD, Hideo Yagita, PhD, Akemi Koyanagi,
Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase 
Individual IL-3 priming is crucial for consistent in vitro activation of donor basophils in patients with chronic urticaria  Thomas Gentinetta, MSc, Tatjana.
Staphylococcal exotoxins are strong inducers of IL-22: A potential role in atopic dermatitis  Margarete Niebuhr, MD, Helena Scharonow, MS, Merle Gathmann,
Sabah El-Ghaiesh, MSc, Joseph P
Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: Comparison of patients with and without anti-FcϵRI or anti-IgE autoantibodies 
Direct ex vivo analysis of allergen-specific CD4+ T cells
Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria  Janine Gericke, PhD, Martin Metz, MD, Tatevik Ohanyan,
Autophagy: Nobel Prize 2016 and allergy and asthma research
Allergen-specific CD8+ T cells in peanut-allergic individuals
Association between specific timothy grass antigens and changes in TH1- and TH2-cell responses following specific immunotherapy  Véronique Schulten, PhD,
Matthew J. Loza, PhD, Susan Foster, PhD, Stephen P
Sara Paveglio, PhD, MS, Erin Bennett, MS, Kelly L. Hawley, PhD, Adam P
Effect of aging on sputum inflammation and asthma control
Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency  Sayed Mahdi Marashi, PhD, Mohammed.
Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5− TH2 responses  Calman Prussin, MD, Joohee Lee,
Ellen Mueller Fox, PhD, Marina N
Systemic and localized seminal plasma hypersensitivity patients exhibit divergent immunologic characteristics  Debajyoti Ghosh, PhD, Jonathan A. Bernstein,
Human basophils may not undergo modulation by DC-SIGN and mannose receptor– targeting immunotherapies due to absence of receptors  Mrinmoy Das, MSc, Caroline.
Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients  Suresh Pallikkuth, PhD, Sudheesh Pilakka.
Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection  Alexander A. Navarini, MD, PhD, Lars E.
IgG4 production is confined to human IL-10–producing regulatory B cells that suppress antigen-specific immune responses  Willem van de Veen, MSc, Barbara.
Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase 
Natural history of cow’s milk allergy
Perturbations of natural killer cell regulatory functions in respiratory allergic diseases  Francesca Scordamaglia, MD, Mirna Balsamo, PhD, Antonio Scordamaglia,
Comparison of the allergic and nonallergic CD4+ T-cell responses to the major dog allergen Can f 1  Suvi Parviainen, MSc, Antti Taivainen, MD, PhD, Aino.
Presentation transcript:

Autoreactive T cells in chronic spontaneous urticaria target the IgE Fc receptor Iα subunit  Priscilla Auyeung, PhD, Diana Mittag, PhD, Philip D. Hodgkin, PhD, Leonard C. Harrison, DSc  Journal of Allergy and Clinical Immunology  Volume 138, Issue 3, Pages 761-768.e4 (September 2016) DOI: 10.1016/j.jaci.2016.04.036 Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 T-cell proliferation to FcεRIα. A and B, CFSE-labeled PBMCs from a subject with CSU. Fig 1, A, Red rectangles: divided (CFSElo) CD4+ as percent of total CD4+ T cells. Fig 1, B, Antigen dose-response (mean ± SD of triplicates). C and D, CFSE-labeled PBMCs from CSU, DC, and HC subjects. Fig 1, C, Left: median CD4+ T-cell proliferation for individual subjects. Right: normalized data (background subtracted) to allow comparison between groups. Fig 1, D, CD8+ T-cell proliferation, as per subjects in Fig 1, C. Dotted lines: cutoffs for positive responses to FcεRIα (>2 interquartile ranges above the median HC value). Solid horizontal lines: group medians. CFSE, Carboxy-fluorescein diacetate succinimidyl ester. Journal of Allergy and Clinical Immunology 2016 138, 761-768.e4DOI: (10.1016/j.jaci.2016.04.036) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 IFN-γ, IL-5, and IL-13 response to FcεRIα by ELISpot assay. A, PBMCs from subjects with CSU (mean ± SD of triplicates). B, PBMCs from CSU, DC, and HC subjects (median IFN-γ, IL-5, and IL-13 spots for individual subjects). C, Normalized data (background subtracted) to allow comparison between groups. Dotted lines: cutoffs for positive responses to FcεRIα (>2 interquartile ranges above the median HC value). Solid horizontal lines: group medians. aResponses to 0.1 vs 0 μM FcεRIα in each group were compared by using the Wilcoxon matched-pairs signed rank test. bBasal secretion between groups was compared by using the Kruskal-Wallis test. Journal of Allergy and Clinical Immunology 2016 138, 761-768.e4DOI: (10.1016/j.jaci.2016.04.036) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Serum autoantibodies to FcεRIα. A, Immunoprecipitation of 125I-FcεRIα by autoantibodies in serum (1:100) from CSU, DC, and HC subjects. Dotted line indicates cutoff for a positive response to FcεRIα (>2 interquartile ranges above the median HC value). Solid horizontal lines denote group medians. B, Serum samples from 8 subjects with CSU were preincubated with unlabelled FcεRIα before incubation with 125I-FcεRIα. Median of triplicates shown for each subject. Journal of Allergy and Clinical Immunology 2016 138, 761-768.e4DOI: (10.1016/j.jaci.2016.04.036) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 IFN-γ and autoantibody responses to FcεRIα. A, Comparison of IFN-γ and autoantibody responses to FcεRIα in 30 subjects with CSU. Median of replicates shown for each subject. B, Comparison of disease duration at the time of study in subjects with CSU with IFN-γ and autoantibody responses to FcεRIα. Journal of Allergy and Clinical Immunology 2016 138, 761-768.e4DOI: (10.1016/j.jaci.2016.04.036) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 5 CD4+ T-cell proliferative, IFN-γ, IL-5 and IL-13 ELISpot, and autoantibody responses to FcεRIα in subjects with CSU. Data from 30 subjects with CSU. IFN-γ, IL-5, and IL-13 ELISpot data are combined. Percentages of subjects with responses are shown. Journal of Allergy and Clinical Immunology 2016 138, 761-768.e4DOI: (10.1016/j.jaci.2016.04.036) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions